Barry J. Simon, Director at ImmunityBio, Inc. (IBRX), sold 150,000 shares at $12.01 ($1.8M) on 2026-02-24, disclosed to the SEC on 2026-02-26.
Open-market sale of $1.8M IBRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 75,000 | $901K | 50.0% |
| 2 | $12.01 | 75,000 | $901K | 50.0% |
| Total | $12.01 avg | 150,000 | $1.8M | 100% |
| Filing → |
| IBRX | SELL | 2026-06-05 | $165K | — | Filing → |
| IBRX | SELL | 2026-02-24 | $3.5M | — | Filing → |
| IBRX | SELL | 2026-01-21 | $1.1M | — | Filing → |